Cargando…

AMPK activation protects from neuronal dysfunction and vulnerability across nematode, cellular and mouse models of Huntington's disease

The adenosine monophosphate activated kinase protein (AMPK) is an evolutionary-conserved protein important for cell survival and organismal longevity through the modulation of energy homeostasis. Several studies suggested that AMPK activation may improve energy metabolism and protein clearance in th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vázquez-Manrique, Rafael P., Farina, Francesca, Cambon, Karine, Dolores Sequedo, María, Parker, Alex J., Millán, José María, Weiss, Andreas, Déglon, Nicole, Neri, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2016
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4764188/ https://www.ncbi.nlm.nih.gov/pubmed/26681807 http://dx.doi.org/10.1093/hmg/ddv513

Ejemplares similares

Metformin intake associates with better cognitive function in patients with Huntington's disease
por: Hervás, David, et al.
Publicado: (2017)

Metformin treatment reduces motor and neuropsychiatric phenotypes in the zQ175 mouse model of Huntington disease
por: Sanchis, Ana, et al.
Publicado: (2019)

Mn(II) Quinoline Complex (4QMn) Restores Proteostasis and Reduces Toxicity in Experimental Models of Huntington’s Disease
por: Merino, Marián, et al.
Publicado: (2022)

Synergistic activation of AMPK prevents from polyglutamine-induced toxicity in Caenorhabditis elegans
por: Gómez-Escribano, AP, et al.
Publicado: (2020)

Mitogen- and stress-activated protein kinase 1-induced neuroprotection in Huntington's disease: role on chromatin remodeling at the PGC-1-alpha promoter
por: Martin, Elodie, et al.
Publicado: (2011)

AMPK amplifies Huntington's disease
por: Short, Ben
Publicado: (2011)

Reactive Species in Huntington Disease: Are They Really the Radicals You Want to Catch?
por: Bono-Yagüe, José, et al.
Publicado: (2020)

Striatal Vulnerability in Huntington’s Disease: Neuroprotection Versus Neurotoxicity
por: Morigaki, Ryoma, et al.
Publicado: (2017)

Loss of the thyroid hormone-binding protein Crym renders striatal neurons more vulnerable to mutant huntingtin in Huntington's disease
por: Francelle, Laetitia, et al.
Publicado: (2015)

USH2A Gene Editing Using the CRISPR System
por: Fuster-García, Carla, et al.
Publicado: (2017)

Nuclear translocation of AMPK-α1 potentiates striatal neurodegeneration in Huntington’s disease
por: Ju, Tz-Chuen, et al.
Publicado: (2011)

Structural neuroimaging differentiates vulnerability from disease manifestation in colombian families with Huntington's disease
por: Valdés Hernández, Maria del C., et al.
Publicado: (2019)

Evaluation of Dimebon in cellular model of Huntington's disease
por: Wu, Jun, et al.
Publicado: (2008)

Biological Aging and the Cellular Pathogenesis of Huntington’s Disease
por: Machiela, Emily, et al.
Publicado: (2020)

DISC1 and Huntington's Disease – Overlapping Pathways of Vulnerability to Neurological Disorder?
por: Boxall, Ruth, et al.
Publicado: (2011)

Transcriptional vulnerabilities of striatal neurons in human and rodent models of Huntington’s disease
por: Matsushima, Ayano, et al.
Publicado: (2023)

Possible involvement of self-defense mechanisms in the preferential vulnerability of the striatum in Huntington's disease
por: Francelle, Laetitia, et al.
Publicado: (2014)

Impaired XK recycling for importing manganese underlies striatal vulnerability in Huntington's disease
por: Chhetri, Gaurav, et al.
Publicado: (2022)

The stress response factor daf-16/FOXO is required for multiple compound families to prolong the function of neurons with Huntington’s disease
por: Farina, Francesca, et al.
Publicado: (2017)

Contribution of Neuroepigenetics to Huntington’s Disease
por: Francelle, Laetitia, et al.
Publicado: (2017)

Normal Aging Modulates the Neurotoxicity of Mutant Huntingtin
por: Diguet, Elsa, et al.
Publicado: (2009)

Chemosynthetic ectosymbionts associated with a shallow-water marine nematode
por: Bellec, Laure, et al.
Publicado: (2019)

A tale of two nematodes: Climate mediates mustelid infection by nematodes across the geographical range
por: Zalewski, Andrzej, et al.
Publicado: (2022)

Rectifying rectifier channels in Huntington disease
por: Proft, Juliane, et al.
Publicado: (2014)

AMPK–mTOR Signaling and Cellular Adaptations in Hypoxia
por: Chun, Yoomi, et al.
Publicado: (2021)

Environment-dependent striatal gene expression in the BACHD rat model for Huntington disease
por: Novati, Arianna, et al.
Publicado: (2018)

Infected host responses across entomopathogenic nematode phylogeny
por: Erdogan, Hilal, et al.
Publicado: (2021)

Nematicidal Efficacy of Milbemectin against Root-Knot Nematodes
por: Talavera-Rubia, Miguel, et al.
Publicado: (2020)

Monkey hybrid stem cells develop cellular features of Huntington's disease
por: Laowtammathron, Chuti, et al.
Publicado: (2010)

Mood disorders in Huntington's disease: from behavior to cellular and molecular mechanisms
por: Pla, Patrick, et al.
Publicado: (2014)

Correction of Huntington’s Disease Phenotype by Genistein-Induced Autophagy in the Cellular Model
por: Pierzynowska, Karolina, et al.
Publicado: (2018)

Ginsenoside compound K reduces the progression of Huntington's disease via the inhibition of oxidative stress and overactivation of the ATM/AMPK pathway
por: Hua, Kuo-Feng, et al.
Publicado: (2022)

Progressive alterations in white matter microstructure across the timecourse of Huntington's disease
por: Estevez‐Fraga, Carlos, et al.
Publicado: (2023)

A Nematode of the Mid-Atlantic Ridge Hydrothermal Vents Harbors a Possible Symbiotic Relationship
por: Bellec, Laure, et al.
Publicado: (2018)

Selective vulnerability of Rich Club brain regions is an organizational principle of structural connectivity loss in Huntington’s disease
por: McColgan, Peter, et al.
Publicado: (2015)

Early postnatal behavioral, cellular, and molecular changes in models of Huntington disease are reversible by HDAC inhibition
por: Siebzehnrübl, Florian A., et al.
Publicado: (2018)

AMPK: Regulating Energy Balance at the Cellular and Whole Body Levels
por: Hardie, D. Grahame, et al.
Publicado: (2014)

Indirect inhibition of 26S proteasome activity in a cellular model of Huntington’s disease
por: Hipp, Mark S., et al.
Publicado: (2012)

Expression of genes encoding the calcium signalosome in cellular and transgenic models of Huntington's disease
por: Czeredys, Magdalena, et al.
Publicado: (2013)

Transcriptional Activation of REST by Sp1 in Huntington's Disease Models
por: Ravache, Myriam, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_q2nch1qve4h6rv9507271ab4fv